William Schuyler Jones

William Schuyler Jones

Associate Professor of Medicine

I am an interventional cardiologist with a specific focus on the diagnosis and treatment of patients with vascular disease, and I perform coronary and peripheral angiography and interventions. I have a broad background in cardiovascular site-based research, multicenter clinical trials, clinical event classification, and observational analyses.  Currently, I am helping to lead a Duke Clinical Research Institute (DCRI) effort to coordinate a multinational, multicenter randomized clinical trial evaluating antiplatelet agents in the treatment of patients with peripheral artery disease. I have served as a physician reviewer for the
Clinical Events Classification (CEC) group at the DCRI and have been the Assistant Director of CEC since 2015. I am also the medical director of the Duke Heart Center Clinical Research Unit that manages each clinical research cluster including Cath Lab, EP, Heart Failure, General Cardiology, and Imaging.

Appointments and Affiliations

  • Associate Professor of Medicine
  • Associate Professor in Population Health Sciences
  • Member of the Duke Clinical Research Institute

Contact Information

  • Office Location: 2400 Pratt Street, 7037, Durham, NC 27705
  • Office Phone: (919) 668-8917
  • Email Address: schuyler.jones@duke.edu


  • Duke University, 2005
  • Duke University, 2004
  • M.D. University of Arkansas, Little Rock, 2001

Representative Publications

  • Weissler, EH; Narcisse, DI; Rymer, JA; Armstrong, EJ; Secemsky, E; Gray, WA; Mustapha, JA; Adams, GL; Ansel, GM; Patel, MR; Jones, WS, Characteristics and Outcomes of Patients With Diabetes Mellitus Undergoing Peripheral Vascular Intervention for Infrainguinal Symptomatic Peripheral Artery Disease., Vasc Endovascular Surg, vol 55 no. 2 (2021), pp. 124-134 [10.1177/1538574420968671] [abs].
  • Zeitouni, M; Clare, RM; Chiswell, K; Abdulrahim, J; Shah, N; Pagidipati, NP; Shah, SH; Roe, MT; Patel, MR; Jones, WS, Risk Factor Burden and Long-Term Prognosis of Patients With Premature Coronary Artery Disease., Journal of the American Heart Association, vol 9 no. 24 (2020) [10.1161/JAHA.120.017712] [abs].
  • Weissler, EH; Annapureddy, A; Wang, Y; Secemsky, EA; Shishehbor, MH; Mena-Hurtado, C; Jelani, Q-U-A; Aronow, HD; Tsai, TT; Patel, MR; Curtis, JP; Jones, WS, Paclitaxel-coated devices in the treatment of femoropopliteal stenosis among patients ≥65 years old: An ACC PVI Registry Analysis., American Heart Journal, vol 233 (2020), pp. 59-67 [10.1016/j.ahj.2020.12.004] [abs].
  • Weissler, EH; Jones, WS; Desormais, I; Debus, S; Mazzolai, L; Espinola-Klein, C; Nikol, S; Nehler, M; Sillesen, H; Aboyans, V; Patel, MR, Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy., Atherosclerosis, vol 315 (2020), pp. 10-17 [10.1016/j.atherosclerosis.2020.11.001] [abs].
  • Sullivan, AE; Holder, T; Truong, T; Green, CL; Sofela, O; Dahhan, T; Granger, CB; Jones, WS; Patel, MR, Use of hospital resources in the care of patients with intermediate risk pulmonary embolism., European Heart Journal. Acute Cardiovascular Care (2020) [10.1177/2048872620921601] [abs].